Litigation Details for Sebela International Limited v. Taro Pharmaceuticals U.S.A., Inc. (S.D.N.Y. 2015)
✉ Email this page to a colleague
Sebela International Limited v. Taro Pharmaceuticals U.S.A., Inc. (S.D.N.Y. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-05-14 |
| Court | District Court, S.D. New York | Date Terminated | 2017-11-09 |
| Cause | 35:271 Patent Infringement | Assigned To | William H. Pauley III |
| Jury Demand | Referred To | ||
| Parties | TARO PHARMACEUTICALS U.S.A., INC. | ||
| Patents | 8,778,365; 9,161,914 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Sebela International Limited v. Taro Pharmaceuticals U.S.A., Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Sebela International Limited v. Taro Pharmaceuticals U.S.A., Inc. (S.D.N.Y. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-09-19 | 111 | The two patents-in-suit—U.S. Patent 8,778,365 (the “365 Patent”) and U.S. Patent 9,161,914 (the… 365 Patent, Ex. 1; 914 Patent, Ex. 2, Parts 1 and 2.) The claimed compositions in both Patents have…trolamine" in Claim 17 of the 365 Patent and Claim 21 of the 914 Patent to be "approximately 0.17 wt % trolamine…the “914 Patent”) (collectively, the “Patents”)—are directed to topical 1 Sebela replaced the…is found in Claim 17 of the 365 Patent and Claim 21 of the 914 Patent, both of which state the following | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
